Anti-Thymocyte Globulin Induction to Prevent Renal Dysfunction: It Necessary Today?

被引：0
|
作者：
Kittleson, M. [1 ]
Patel, J. [1 ]
Hamilton, M. [1 ]
Yu, Z. [1 ]
Liou, F. [1 ]
Yabuno, J. [1 ]
Azarbal, B. [1 ]
Chang, D. [1 ]
Geft, D. [1 ]
Kobashigawa, J. [1 ]
机构：
[1] Cedars Sinai Heart Inst, Los Angeles, CA USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-00183
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1371
引用
收藏
页码：56 / 57
页数：2
相关论文
共 50 条
  • [21] Clinical Experience of 6 Years with Rabbit Anti-Thymocyte Globulin as Induction Therapy in Renal Transplant Receptors
    Robledo, Arlette
    Vidana, Gabriela
    Cruz, Jose
    Diaz, Ana
    Lopez, Pedro
    Garcia, Catalina
    Olvera, Jose M.
    Meza, Guillermo
    Bernaldez, German
    Medina, Carlos
    TRANSPLANTATION, 2018, 102 : S596 - S596
  • [22] A prospective randomized comparison of alemtuzumab versus rabbit anti-thymocyte globulin induction in renal and pancreas transplantation
    Stratta, Robert
    Ashcraft, Elizabeth
    Hartmann, Erica
    Rogers, Jeff
    Doares, William
    Hart, Lois
    Gautreaux, Michael
    Adams, Patricia
    Farney, Alan
    TRANSPLANT INTERNATIONAL, 2007, 20 : 127 - 127
  • [23] CONTROLLED REASSESSMENT OF THE USE OF ANTI-THYMOCYTE GLOBULIN (ATG) TO PREVENT REJECTION OF CADAVERIC RENAL-ALLOGRAFTS (CTX)
    GAILIUNAS, P
    HELDERMAN, JH
    ATKINS, C
    PETERS, P
    HULL, A
    KIDNEY INTERNATIONAL, 1981, 19 (01) : 266 - 266
  • [24] Induction immunosuppression with rabbit anti-thymocyte globulin in pediatric liver transplantation.
    Shah, AP
    Agarwal, A
    Mangus, RS
    Lim, JD
    Molleston, JP
    Tector, AJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 340 - 340
  • [25] Experience with alemtuzumab versus rabbit anti-thymocyte globulin induction in pancreas transplantation
    Farney, Alan C.
    Singh, Rajinder P.
    Rogers, Jeffrey
    Ashcraft, Elizabeth
    Doares, William
    Hartmann, Erica L.
    Reeves-Daniel, Amber
    Gautreaux, Michael
    Adams, Patricia L.
    Stratta, Robert J.
    XENOTRANSPLANTATION, 2007, 14 (05) : 382 - 382
  • [26] THE TREATMENT OF LYMPHOBLASTIC LYMPHOMA WITH ANTI-THYMOCYTE GLOBULIN
    WONG, KK
    SWEET, DL
    VARIAKOJIS, D
    CANCER, 1982, 50 (01) : 57 - 61
  • [27] RABBIT ANTI-THYMOCYTE GLOBULIN (rATG)-BASED IMMUNOSUPPRESSION INDUCTION IN KIDNEY TRANSPLANTATION
    Goggins, William C.
    Qualey, Angie
    Taber, Tim
    Powelson, John
    Chen, Jeanne
    Robertson, Chris
    Mangus, Richard S.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 180 - 180
  • [28] Optimal Anti-Thymocyte Globulin Dose for Induction Immunosuppression in Kidney Transplantation.
    Mitrokhin, A.
    Goldman, J.
    Trivedi, B.
    Vidyasagar, V.
    Vadivel, N.
    Hart, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 676 - 676
  • [29] IMMUNOSUPPRESSIVE EFFECTIVENESS OF ANTI-THYMOCYTE GLOBULIN (ATG) CORRELATES WITH INDUCTION OF SUPPRESSOR CELLS
    THOMAS, FT
    CARVER, FM
    THOMAS, JM
    TRANSPLANTATION PROCEEDINGS, 1983, 15 (03) : 1868 - 1869
  • [30] Anti-Thymocyte Globulin Induction in Infected Mechanical Circulatory Support Patients: Is It Safe?
    Jamero, G.
    Moriguchi, J.
    Czer, L.
    Kittleson, M.
    Siddiqui, S.
    Liou, F.
    Arman, D.
    Lam, L.
    Chang, D.
    Zakowski, P.
    Kobashigawa, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
12345